Brief: Ampio Pharma Says Based On Assessment, Management Has Raised Concerns About Ability To Continue As A Going Concern

Ampio Pharmaceuticals

21/02/2020 13:09

Feb 21 (Reuters) - Ampio Pharmaceuticals Inc  AMPE.A :
    * AMPIO PHARMACEUTICALS INC SAYS BASED ON ASSESSMENT,
MANAGEMENT
HAS RAISED CONCERNS ABOUT ABILITY TO CONTINUE AS A GOING CONCERN
- SEC FILING
    * AMPIO PHARMACEUTICALS - IN ADDITION, CO'S INDEPENDENT
REGISTERED
PUBLIC ACCOUNTING FIRM EXPRESSED SUBSTANTIAL DOUBT AS TO ABILITY
TO CONTINUE AS GOING CONCERN
    * AMPIO PHARMACEUTICALS - AS OF DECEMBER 31, 2019, HAD $6.5
MILLION OF CASH AND CASH EQUIVALENTS WHICH EXPECT CAN FUND
OPERATION INTO Q2 OF 2020

Source text: [http://bit.ly/2T64Ih5]
Further company coverage:  AMPE.A 

 (Reuters.Briefs@thomsonreuters.com)